Literature DB >> 17113240

Effectiveness of complete diagnostic examination in clinical practice settings.

Masahito Jimbo1, Birgit Meyer, Terry Hyslop, James Cocroft, Barbara J Turner, David S Weinberg, Ronald E Myers.   

Abstract

BACKGROUND: Thorough follow-up of a positive fecal occult blood test (FOBT) result, or a complete diagnostic evaluation (CDE), is recommended as routine care on the basis of findings from colorectal cancer (CRC) screening trials. CDE involves either colonoscopy or the combination of flexible sigmoidoscopy and double contrast barium enema X-ray. However, little evidence outside clinical screening trial settings has been reported in the literature to support CDE performance. The focus of this study was to determine the impact of CDE in primary care practice settings.
METHODS: We determined diagnostic outcomes for 461 adult patients with a positive FOBT result in 318 primary care practices in southeastern Pennsylvania and southern New Jersey. Sociodemographic data were collected and CDE status was ascertained for these patients. Polytomous logistic models were used to identify whether having CDE was associated with subsequently being diagnosed with lower gastrointestinal "neoplastic disease" or "other gastrointestinal disease" as compared to "normal findings.
RESULTS: Patients who underwent CDE were significantly more likely to have a reported diagnosis of colorectal neoplasia than normal findings (adjusted odds ratio = 3.65, 95% confidence interval = 1.58-8.39, p = 0.02). CDE performance did not result in the differential diagnosis of other gastrointestinal disease.
CONCLUSIONS: Patients with a positive screening FOBT who underwent CDE were more likely to be diagnosed with colorectal neoplasia than with less serious conditions or have normal findings. Results support the use of CDE in CRC screening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113240      PMCID: PMC1861814          DOI: 10.1016/j.cdp.2006.10.001

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  16 in total

1.  Measuring complete diagnostic evaluation in colorectal cancer screening.

Authors:  R E Myers; G Fishbein; T Hyslop; W W Hauck; M Kutch; J R Grana; N Schlackman
Journal:  Cancer Detect Prev       Date:  2001

2.  Screening for colorectal cancer: recommendation and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

Review 3.  American Cancer Society Guidelines for the Early Detection of Cancer, 2005.

Authors:  Robert A Smith; Vilma Cokkinides; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

5.  Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.

Authors:  R E Myers; B Turner; D Weinberg; W W Hauck; T Hyslop; T Brigham; T Rothermel; J Grana; N Schlackman
Journal:  Prev Med       Date:  2001-10       Impact factor: 4.018

6.  Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.

Authors:  V K Sharma; R Vasudeva; C W Howden
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

7.  Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Authors:  Nadeem Baig; Ronald E Myers; Barbara J Turner; James Grana; Todd Rothermel; Neil Schlackman; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

8.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

9.  A critical analysis of the largest reported mass fecal occult blood screening program in the United States.

Authors:  J B Morris; T A Stellato; B B Guy; N H Gordon; N A Berger
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  Impact of a physician-oriented intervention on follow-up in colorectal cancer screening.

Authors:  Ronald E Myers; Barbara Turner; David Weinberg; Terry Hyslop; Walter W Hauck; Timothy Brigham; Todd Rothermel; James Grana; Neil Schlackman
Journal:  Prev Med       Date:  2004-04       Impact factor: 4.018

View more
  1 in total

1.  A computerized intervention to promote colorectal cancer screening for underserved populations: theoretical background and algorithm development.

Authors:  K Allen Greiner; Mugur V Geana; Aaron Epp; Angela Watson; Melissa Filippi; Christine Makosky Daley; Kimberly K Engelman; Aimee S James; Marci Campbell
Journal:  Technol Health Care       Date:  2012       Impact factor: 1.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.